Español

CONTACT


    DR. LETICIA PÉREZ SALEME

    Education:

    • 1998 – Specialty in Infectology, INNSZ.
    • 1996 – Specialty in Internal Medicine, INNSZ.
    • 1993 – Surgeon, National Autonomous University of Mexico.

    Academic appointments:

    • Infectious disease doctor at Hospital Ángeles Pedregal.
    • President of the CISIDAT Secretariat.
    • Physician attached to the Infectology Service of the Department of Internal Medicine of the Hospital de Especialidades del Centro Médico Nacional Siglo XXI (IMSS), 1998-2019.
    • Member of the American College of Physicians, of the Association of Internal Medicine of Mexico, of the Association
    • Mexicana de Infectología y Microbiología Clínica and the Mexican Medical Association of HIV / AIDS.
    • Researcher affiliated with CISIDAT.

    Research interests:

    • HIV, antiretroviral therapy, and adverse effects of antiretroviral therapy.

    Featured projects:

    • Status of the human immunodeficiency virus epidemic in the Mexican Institute of Social Security 2015-2017.

    SELECTED PUBLICATIONS

    • Prospective, randomized, open label trial of Efavirenz vs Lopinavir/Ritonavir in HIV+ treatment-naive subjects with CD4+<200 cell/mm3 in Mexico. Sierra-Madero J, Villasis-Keever A, Méndez P, Mosqueda-Gómez JL, Torres-Escobar I, Gutiérrez-Escolano F, Juárez-Kasusky I, Magana-Aquino M, Ramos-Santos C, Pérez-Saleme L, Rangel-Frausto S, Antuna-Puente B, Soto-Ramírez LE, Lima V, Belaunzarán-Zamudio F, Crabtree-Ramírez B, Montaner J. J Acquir Immune Defic Syndr. 2010 Apr;53(5):582-8.
    • [Antiretroviral treatment guide for adult people living with HIV/AIDS]. Soto-Ramírez LE, Pérez-Saleme L, Hernandez-Tepichin G, Sierra-Madero J, León-Juárez EA, Romo-García J, Rangel-Frausto S, Gaona-Flores V, Jáuregui-Chiu M, López-Martínez C, Vázquez-Valls E, Varela-Trejo C; Grupo de Tratamiento en Adultos del Comité de Atención Integral de CENSIDA. Rev Invest Clin. 2004 Mar-Apr;56(2):253-71.
    • Rheumatic manifestations of human immunodeficiency virus infection. Medina F, Pérez-Saleme L, Moreno J. Infect Dis Clin North Am. 2006 Dec;20(4):891-912.
    • First HAART in HIV-infected patients with high viral load: value of HIV RNA levels at 12 weeks to predict virologic outcome. Townsend D, Troya J, Maida I, Pérez-Saleme L, Satta G, Wilkin A, Barreiro P, Pegram PS, Soriano V, Mura MS, Núñez M. J Int Assoc Physicians AIDS Care (Chic). 2009 Sep-Oct;8(5):314-7.
    • [Epidemiology of HIV infection: twenty-years of experience]. Pérez-Saleme LM, Hernández-Tepichin G. Rev Invest Clin. 2004 Mar-Apr;56(2):134-42.
    • Virological rather than host factors are associated with transaminase levels among HIV/HCV-coinfected patients. Shores NJ, Maida I, Perez-Saleme L, Núñez M. J Int Assoc Physicians AIDS Care (Chic). 2010 Jan-Feb;9(1):15-9.
    • Profile of patients triply infected with HIV and the hepatitis B and C viruses in the HAART era. Maida I, Ríos MJ, Pérez-Saleme L, Ramos B, Soriano V, Pegram PS, Mura MS, Sánchez-Margalet V, Saldívar-Cornejo I, Wilkin A, Babudieri S, Núñez M. AIDS Res Hum Retroviruses. 2008 May;24(5):679-83.
    • [A fifty-six year old woman with painful nodules and skin ulcers]. Sánchez-Hurtado LA, Zapata-Altamirano LE, Pérez-Sáleme L. Gac Med Mex. 2006 Jul-Aug;142(4):333-5.